Biotech
AmplifyBio
AmplifyBio raises $50M Growth at $280M valuation
New Albany, OHNovember 7, 20241 min read
Latest funding
$50M
Valuation
$280M
Latest Round
Growth
Employees
400+
AmplifyBio: Growth Funding Round
AmplifyBio has successfully raised $50M in Growth funding, reaching a valuation of $280M.
Company Overview
Drug development company providing preclinical and clinical services
Funding Details
The Growth round was led by Vitrian, with participation from Safar Partners.
Company Information
- Headquarters: New Albany, OH
- Founded: 2020
- Employees: 400+
- Category: Biotech
Investment
AmplifyBio plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Vitrian: Verified investor in Growth
- Safar Partners: Verified investor in Growth
Company Info
Headquarters
New Albany, OH
Founded
2020
Team Size
400+
Last Round
$50M(Nov 2024)
Investors (2)
V
VitrianLeadLead Investor
Verified investor in Growth
S
Safar PartnersInvestor
Verified investor in Growth
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started